Volume 16, Issue 2 (March & April-In Press 2026)
J Research Health 2026, 16(2): 4-4 |
Back to browse issues page
Ethics code: No: 370/367KEPK-LE/LL-02/2023
Download citation:
BibTeX | RIS | EndNote | Medlars | ProCite | Reference Manager | RefWorks
Send citation to:
BibTeX | RIS | EndNote | Medlars | ProCite | Reference Manager | RefWorks
Send citation to:
Hasanah U, Mohd Noh M, Arsat N, Ping Pang N T. Group Cognitive Behaviour Therapy Combined with Mindfulness on Quality of Life and Clinical Outcomes in Haemodialysis Patients: A Quasi-Experimental Study. J Research Health 2026; 16 (2) :4-4
URL: http://jrh.gmu.ac.ir/article-1-2817-en.html
URL: http://jrh.gmu.ac.ir/article-1-2817-en.html
1- Faculty of Health Sciences, Universitas Dharma Wacana, Lampung, Indonesia
2- Faculty of Medicine and Health Sciences, Universiti Malaysia Sabah, Kinabalu, Malaysia
2- Faculty of Medicine and Health Sciences, Universiti Malaysia Sabah, Kinabalu, Malaysia
Abstract: (6 Views)
Background: Quality of life (QoL) of patients undergoing haemodialysis is often affected by many factors, including clinical and physiological status. The aim of this study was to determine the effect of Group Cognitive Behaviour Therapy (CBT) with mindfulness on QoL and clinical outcomes in haemodialysis patients.
Methods: This study used quasi-experimental pre post-test design, involving 66 respondents divided into control and intervention groups. Purposive sampling was used to select respondents who met the inclusion criteria. The intervention group was given Group CBT with mindfulness, the control group received standard care. This therapy delivered in 7 sessions over 6 weeks. Each session lasts 45–60 minutes. Clinical outcomes and QoL were measured before and after intervention. QoL was measured using KDQOL SF-36. Clinical outcomes were measured using haematology analyser, Sysmex XN-1000. Clinical outcomes in this study included erythrocytes, haemoglobin, and haematocrit. Statistical analysis used paired t-tests to measure QoL and Wilcoxon tests for clinical outcomes.
Results: The results showed significant improvement in QoL (SD 7.40; MD -16.00; p-value: 0.000) and improved clinical outcomes: erythrocytes (MD 0.292; SD 0.415; p-value: 0.000); haemoglobin (MD 1.042; SD 1.268; p-value: 0.000); haematocrit (MD 2.509; SD 3.488; p-value: 0.003). From statistical test, there were significant differences in QoL and clinical outcomes between those receiving Group CBT with mindfulness and those receiving standard care (p-values < 0.05).
Conclusion: The results of this study provide justification that Group CBT with mindfulness can be an effective and sustainable solution in improving QoL and clinical outcomes for haemodialysis patients.
Methods: This study used quasi-experimental pre post-test design, involving 66 respondents divided into control and intervention groups. Purposive sampling was used to select respondents who met the inclusion criteria. The intervention group was given Group CBT with mindfulness, the control group received standard care. This therapy delivered in 7 sessions over 6 weeks. Each session lasts 45–60 minutes. Clinical outcomes and QoL were measured before and after intervention. QoL was measured using KDQOL SF-36. Clinical outcomes were measured using haematology analyser, Sysmex XN-1000. Clinical outcomes in this study included erythrocytes, haemoglobin, and haematocrit. Statistical analysis used paired t-tests to measure QoL and Wilcoxon tests for clinical outcomes.
Results: The results showed significant improvement in QoL (SD 7.40; MD -16.00; p-value: 0.000) and improved clinical outcomes: erythrocytes (MD 0.292; SD 0.415; p-value: 0.000); haemoglobin (MD 1.042; SD 1.268; p-value: 0.000); haematocrit (MD 2.509; SD 3.488; p-value: 0.003). From statistical test, there were significant differences in QoL and clinical outcomes between those receiving Group CBT with mindfulness and those receiving standard care (p-values < 0.05).
Conclusion: The results of this study provide justification that Group CBT with mindfulness can be an effective and sustainable solution in improving QoL and clinical outcomes for haemodialysis patients.
Type of Study: Orginal Article |
Subject:
● Psychosocial Health
Received: 2025/06/7 | Accepted: 2025/09/20 | Published: 2026/03/21
Received: 2025/06/7 | Accepted: 2025/09/20 | Published: 2026/03/21
| Rights and permissions | |
 |
This work is licensed under a Creative Commons Attribution-NonCommercial 4.0 International License. |
This is an open access article distributed under the terms of the Creative Commons Attribution License (CC-By-NC), which permits use, distribution, and reproduction in any medium, provided the original work is properly cited and is not used for commercial purposes.
Contact Information
